US Bancorp Portfolio holdings
US Bancorp is the parent company of U.S. Bank, which provides banking, investment, mortgage, trust and payment services to individuals, businesses, governments and other financial institutions. It traces its founding to 1863 and First National Bank of Cincinnati, whose national charter it still operates under. Its present form dates to 2001, when Firstar Corporation of Milwaukee bought the earlier U.S. Bancorp, a holding company that began in Oregon in 1969, and the merged company took that name. In 2022 it completed the purchase of MUFG Union Bank's consumer business, which gave it a large presence on the West Coast, especially in California.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$43M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$29.1M |
| 3 |
iShares TIPS Bond ETF
TIP
|
+$28.4M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$27.3M |
| 5 |
Amazon
AMZN
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$44.4M |
| 2 |
US Bancorp
USB
|
+$24.3M |
| 3 |
STJ
St Jude Medical
STJ
|
+$23.2M |
| 4 |
Spectra Energy Corp Wi
SE
|
+$20.8M |
| 5 |
Vanguard Long-Term Bond ETF
BLV
|
+$18.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.3% |
| 2 | Industrials | 12.24% |
| 3 | Financials | 11.35% |
| 4 | Healthcare | 10.71% |
| 5 | Technology | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
State Street SPDR S&P 500 ETF Trust
SPY
$796B
| $1.31B | 4.49% |
5,561,201
+30,880
| +0.6% | +$7.18M |
2013 Q2
15 quarters
|
|
2
3M
MMM
$95.3B
| $1.01B | 3.46% |
6,315,248
-31,828
| -0.5% | -$4.88M |
2013 Q2
15 quarters
|
|
|
3
US Bancorp
USB
$94.7B
| $716M | 2.45% |
13,898,733
-456,260
| -3% | -$24.3M |
2013 Q2
15 quarters
|
|
|
4
iShares MSCI EAFE ETF
EFA
$77B
| $600M | 2.06% |
9,630,848
+482,014
| +5% | +$29.1M |
2013 Q2
15 quarters
|
|
5
ExxonMobil
XOM
$690B
| $582M | 1.99% |
7,098,106
-174,725
| -2% | -$14.6M |
2013 Q2
15 quarters
|
|
6
Procter & Gamble
PG
$393B
| $558M | 1.91% |
6,205,465
+26,755
| +0.4% | +$2.37M |
2013 Q2
15 quarters
|
|
7
Apple
AAPL
$5.2T
| $555M | 1.9% |
15,461,696
-375,892
| -2% | -$12.4M |
2013 Q2
15 quarters
|
|
8
Johnson & Johnson
JNJ
$689B
| $491M | 1.68% |
3,940,250
-30,578
| -0.8% | -$3.65M |
2013 Q2
15 quarters
|
|
9
iShares Core US Aggregate Bond ETF
AGG
$137B
| $470M | 1.61% |
4,328,573
+149,110
| +4% | +$16.1M |
2013 Q2
15 quarters
|
|
10
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.2B
| $446M | 1.53% |
1,428,510
+49,807
| +4% | +$15.5M |
2013 Q2
15 quarters
|
|
11
Microsoft
MSFT
$3.88T
| $404M | 1.38% |
6,133,622
-97,733
| -2% | -$6.26M |
2013 Q2
15 quarters
|
|
12
GE Aerospace
GE
$343B
| $335M | 1.15% |
2,344,117
-20,956
| -0.9% | -$3.03M |
2013 Q2
15 quarters
|
|
|
13
iShares Core MSCI EAFE ETF
IEFA
$191B
| $327M | 1.12% |
5,637,857
+764,732
| +16% | +$43M |
2014 Q2
11 quarters
|
|
14
JPMorgan Chase
JPM
$915B
| $312M | 1.07% |
3,548,175
+69,044
| +2% | +$6.09M |
2013 Q2
15 quarters
|
|
15
Pfizer
PFE
$164B
| $304M | 1.04% |
9,357,877
-53,668
| -0.6% | -$1.69M |
2013 Q2
15 quarters
|
|
16
iShares Core S&P Small-Cap ETF
IJR
$106B
| $296M | 1.01% |
4,273,920
+251,620
| +6% | +$17.4M |
2013 Q2
15 quarters
|
|
17
Wells Fargo
WFC
$258B
| $290M | 0.99% |
5,215,265
-206,751
| -4% | -$11.7M |
2013 Q2
15 quarters
|
|
18
PepsiCo
PEP
$197B
| $290M | 0.99% |
2,590,499
-20,265
| -0.8% | -$2.17M |
2013 Q2
15 quarters
|
|
19
Vanguard Morningstar Total Stock Market ETF
VTI
$685B
| $273M | 0.94% |
2,254,202
-56,912
| -2% | -$6.82M |
2013 Q2
15 quarters
|
|
20
Chevron
CVX
$425B
| $269M | 0.92% |
2,506,654
-31,933
| -1% | -$3.58M |
2013 Q2
15 quarters
|
|
21
Vanguard Real Estate ETF
VNQ
$38.6B
| $244M | 0.84% |
2,958,519
-14,286
| -0.5% | -$1.19M |
2013 Q2
15 quarters
|
|
22
iShares MSCI Emerging Markets ETF
EEM
$28B
| $218M | 0.75% |
5,532,168
-54,782
| -1% | -$2.08M |
2013 Q2
15 quarters
|
|
23
General Mills
GIS
$18.3B
| $213M | 0.73% |
3,611,771
-32,683
| -0.9% | -$2M |
2013 Q2
15 quarters
|
|
24
iShares Select Dividend ETF
DVY
$23.7B
| $209M | 0.72% |
2,291,794
+35,908
| +2% | +$3.25M |
2013 Q2
15 quarters
|
|
25
AT&T
T
$149B
| $203M | 0.7% |
6,473,587
+183,304
| +3% | +$5.77M |
2013 Q2
15 quarters
|
|
Similar funds
US Bancorp's Q1 2017 Portfolio in Review
As of Q1 2017, US Bancorp held 3,780 positions worth $29.2B, up 5% from $27.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q1 2017 filing shows 179 new, 1,287 increased, 1,288 reduced and 176 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 37,511 shares worth $2.04M. The largest sale was Berkshire Hathaway Class A, an estimated $44.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Industrials and Financials.
- US Bancorp's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 37,511 shares worth $2.04M.
- US Bancorp added most to iShares Core MSCI EAFE ETF in Q1 2017, an estimated $43M increase.
- US Bancorp's biggest Q1 2017 reduction was Berkshire Hathaway Class A, cutting an estimated $44.4M.
- US Bancorp fully exited St Jude Medical in Q1 2017, selling an estimated $23.2M.
- US Bancorp's ten largest holdings make up 23% of its $29.2B portfolio in Q1 2017.
- US Bancorp opened 179 new positions and closed 176 in Q1 2017.
- US Bancorp's portfolio value rose 5% quarter-over-quarter to $29.2B.
Based on US Bancorp's 13F filing for Q1 2017, filed 3 May 2017.